Product information
Product Overview
Retatrutide is a triple agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation. This multi-receptor activation profile makes retatrutide a valuable research tool for investigating coordinated metabolic signalling, receptor crosstalk, and integrated pathway regulation in laboratory models.
Related: GLP-1 & Metabolic Peptides | Retatrutide Research Guide | Compare with Semaglutide
Technical Specifications
Batch-specific third-party documentation available. Reports may include testing from independent laboratories such as Janoshik, Chromate, and Freedom Diagnostics, depending on the batch. View our COA & Lab Testing page for details.
Research Applications
- Triple Receptor Agonism Studies: Investigate coordinated activation of GLP-1, GIP, and glucagon receptors in cell-based assays and experimental models.
- Comparative Metabolic Research: Compare multi-receptor activation effects versus selective GLP-1 agonists (semaglutide) or dual agonists (tirzepatide).
- Receptor Crosstalk Investigation: Study synergistic effects and receptor interaction mechanisms in integrated metabolic pathways.
- Analytical Concentration: In-vitro assays typically utilise a range of 1 nM to 1 μM to establish multi-pathway binding metrics.
This analytical standard is strictly for in-vitro laboratory research. View our Research Use Disclaimer for compliance information.